LINTEX
920106
LINGOOD
833284
NTGEC
870436
CG MED EQUIP.
838810
Jiayu Holding
300117
CN Stock MarketDetailed Quotes
002603 Shijiazhuang Yiling Pharmaceutical
- 13.90
- -0.29-2.04%
Market Closed Feb 28 15:00 CST
23.22BMarket Cap156.18P/E (TTM)
14.28High13.88Low176.64KlotVolume14.18Open14.19Pre Close247.93MTurnover1.28%Turnover Ratio17.18P/E (Static)1.67BShares21.8052wk High2.02P/B19.13BFloat Cap13.2552wk Low15.61Limit Up1.38BShs Float53.16Historical High12.77Limit Down2.82%Amplitude4.79Historical Low0.30Dividend TTM14.04Avg Price103.65KlotAsk2.16%Div YieldTTM100Lot Size70.72KlotBid
Shijiazhuang Yiling Pharmaceutical News
Eling Pharmaceutical: Announcement on Supplementary Pledges for Some Shares of Actual Controllers
Eling Pharmaceutical: Notice on obtaining a drug registration certificate for the innovative traditional Chinese medicine, Astragalus nasal medicine tablets
Eling Pharmaceutical: 2024 Annual Results Forecast
Eling Pharmaceutical: Notice on Withdrawal of Clinical Trial Application for G201-Na Capsule Drugs
Eling Pharmaceutical: Announcement on the extension of the actual controller\'s partial share pledge
Eling Pharmaceutical: Notice on approval of the registration application for clinical trials of the new Chinese medicine Lianhua Yuping granular drug
Eling Pharmaceutical: Notice on Wholly Owned Subsidiary Formulation Products Obtaining U.S. FDA Approval Numbers
Eling Pharmaceutical: Announcement on the inclusion of the company\'s drugs in the “National Medical Insurance Catalogue” through negotiations
Eling Pharmaceutical: Record of Investor Relations Activities for October 29, 2024
Eling Pharmaceutical: Report for the third quarter of 2024
Eling Pharmaceutical: Notice on Acceptance of Clinical Trial Applications for Innovative Chemical Drug G201-Na Capsules
Eling Pharmaceutical: Record of Investor Relations Activities on October 15, 2024
Eling Pharmaceutical: Announcement on attending the 2024 Online Group Reception Day for Investors of Listed Companies in Hebei and the 2024 Semi-Annual Report Results Briefing
Eling Pharmaceutical: Announcement on the acceptance of the application for clinical trials of the new traditional Chinese medicine Lianhua Yuping granular drug
Eling Pharmaceutical: Announcement on Release of the Pledge of Part of the Actual Controller\'s Shares
Eling Pharmaceutical: Announcement on the actual controller\'s partial share pledge
Eling Pharmaceutical: Investor Relations Activity Record Form for August 28, 2024
Eling Pharmaceutical: Semi-Annual Report 2024
Eling Pharmaceutical: Announcement of Resolutions of the Supervisory Board in the Semi-Annual Report
Eling Pharmaceutical: Announcement of Board Resolutions of the Semi-Annual Report
